Related Experiment Video

Updated: May 24, 2026

Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow
10:44

Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow

Published on: August 15, 2025

Does a clinical guideline change chlamydia testing? Report from the Waikato Chlamydia Project

Jane Morgan1, Andre Donnell, Anita Bell

  • 1Waikato Hospital, PB3200, Hamilton, New Zealand. jane.morgan@waikatodhb.health.nz

Journal of Primary Health Care
|March 2, 2012
PubMed

Insights

A national chlamydia management guideline did not significantly increase chlamydia testing rates in New Zealand. Efforts to optimize sexual health screening require ongoing evaluation and focus on at-risk populations.

Area of Science:

  • Public Health
  • Sexual Health
  • Infectious Disease Management

Background:

  • Waikato District Health Board piloted a national chlamydia management guideline to improve testing and treatment.
  • Prior New Zealand research indicated that intervention-driven increases in testing may not be sustained.

Purpose of the Study:

  • To evaluate the impact of a national chlamydia management guideline on testing volumes and treatment rates.
  • To assess changes in chlamydia testing uptake by age, gender, and ethnicity following guideline implementation.

Main Methods:

  • Compared district-wide chlamydia test volumes across three periods: before (2008), during (2009), and after (2010) guideline implementation.
  • Calculated crude population test uptake and assessed Azithromycin pharmacy claims for treatment rates.

Main Results:

  • Chlamydia testing uptake among women aged 15-24 was already high (23% in 2008).
  • While testing increased in under-25-year-olds during 2009, the change was not statistically significant or sustained in 2010 (p=0.06).
  • No significant sustained changes in testing were observed based on gender or ethnicity post-implementation.

Conclusions:

  • The guideline did not lead to significant, sustained increases in chlamydia testing across demographic groups.
  • Further research is needed to determine the optimal age threshold for chlamydia screening in New Zealand.
  • Enhancing primary care support, training, and focusing on high-risk groups are crucial for effective sexual health strategies.
Abstract

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...